Skip to main content
Back To Top Top Back To Top
The Legislative Service Commission staff updates the Revised Code on an ongoing basis, as it completes its act review of enacted legislation. Updates may be slower during some times of the year, depending on the volume of enacted legislation.

Section 3707.562 | Authorization to administer overdose reversal drugs; protocol.

 

(A) As used in this section, "service entity" has the same meaning as in section 4729.514 of the Revised Code.

(B) A board of health that has established a protocol under division (D) of this section may authorize an individual who is an employee, volunteer, or contractor of a service entity to administer overdose reversal drugs to an individual who is apparently experiencing an opioid-related overdose.

(C) An individual authorized by a board of health under this section may administer overdose reversal drugs to an individual who is apparently experiencing an opioid-related overdose if both of the following conditions are met:

(1) The authorized individual complies with the protocol established by the board.

(2) The authorized individual summons emergency services as soon as practicable either before or after administering an overdose reversal drug.

(D) A board of health, through a physician serving as the board's health commissioner or medical director, may establish a protocol for administering overdose reversal drugs under this section. The protocol must be established in writing and include all of the following:

(1) A description of the clinical pharmacology of the overdose reversal drugs specified in the protocol;

(2) Precautions and contraindications concerning the administration of overdose reversal drugs;

(3) Any limitations the board specifies concerning the individuals to whom overdose reversal drugs may be administered;

(4) The dosage that may be administered and any variation in the dosage based on circumstances specified in the protocol;

(5) Labeling, storage, record keeping, and administrative requirements;

(6) Training requirements that must be met before an individual can be authorized to administer overdose reversal drugs.

(E) A board that in good faith authorizes an individual to administer overdose reversal drugs under this section is not liable for damages in any civil action for any act or omission of the authorized individual.

A physician serving as a board's health commissioner or medical director who in good faith authorizes an individual to administer overdose reversal drugs under this section is not liable for or subject to any of the following for any act or omission of the authorized individual: damages in any civil action, prosecution in any criminal proceeding, or professional disciplinary action.

A service entity or an employee, volunteer, or contractor of a service entity is not liable for or subject to any of the following for injury, death, or loss to person or property that allegedly arises from an act or omission associated with procuring, maintaining, accessing, or using overdose reversal drugs under this section, unless the act or omission constitutes willful or wanton misconduct: damages in any civil action, prosecution in any criminal proceeding, or professional disciplinary action.

This section does not eliminate, limit, or reduce any other immunity or defense that a service entity or an employee, volunteer, or contractor of a service entity may be entitled to under Chapter 2305. or any other provision of the Revised Code or under the common law of this state.

Last updated October 19, 2022 at 4:08 PM

Available Versions of this Section